Skip to main content
White paper

FTC pharmacy benefit management transparency report: How might pharma evaluate transparency reform impacts to drug channel stakeholders?

By Chad Barker, Chris Page, and Matt Berman
04 September 2024

About the Author(s)

Chad Barker

Indianapolis Tel: 1 317 7096656

View bio

Chris Page

Indianapolis

View bio

Matt Berman

Indianapolis Tel: 1 317 5243558

View bio

We’re here to help

Ask the tough questions. We’re ready for them.

We’re here to help

Ask the tough questions. We’re ready for them.

popup image